Ethylene oligomerization activities of chromium catalysts stabilized by different dipyrrole-based ancillary ligands, [(Ph 2 C(C 4 H 4 N) 2 )] ( 2 ), [Ph 2 C(C 4 H 4 N)(C 5 H 6 N)] ( 3 ), [(Et) 2 C(C 4 H 4 N) 2 ] ( 4 ), and [(C 6 H 5 )(C 5 H 4 N)C(C 4 H 4 N)(C 5 H 6 N)] ( 5 ), have been investigated using different activation methods, and the results have been compared with the commercial Chevron–Phillips ethylene trimerization system. Upon activation with triethylaluminum (TEA), chromium catalysts stabilized by dipyrrole-based ligands 2 – 5 showed a lower activity and selectivity compared to the Chevron–Phillips trimerization system based on 2,5-dimethylpyrrole ( 1 ) as the ancillary ligand. However, unprecedented increases in both activity and selectivity have been observed by carrying out the oligomerization in methylcyclohexane using depleted-methylaluminoxane (DMAO) along with triisobutylaluminum (TIBA) (1:2 ratio) as cocatalyst system under mild conditions, even for the Chevron–Phillips system itself. Well-defined chromium complexes, [(Ph 2 C(C 4 H 3 N) 2 )Cr(Cl)(THF) 3 ] ( 6 ) and {[Ph 2 C(C 4 H 3 N)(C 5 H 6 N]Cr(THF)(μ-Cl)} 2 ( 7 ), have been synthesized and fully characterized. Upon activating with MAO, catalyst 7 produced a statistical distribution of oligomers, whereas under identical oligomerization conditions catalyst 6/ MAO was found to be inactive. The use of MeAlCl 2 as cocatalyst to activate 7 resulted in the switching of the catalyst’s behavior from producing a statistical distribution of LAOs to the selective trimerization of ethylene to 1-hexene. The addition of dialkylzinc along with MAO resulted in an unprecedented activity increase.
No takes yet. Share an insight, caveat, or question.
Kulangara et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: